Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Axsome Therapeutics Inc AXSM

Healthcare Biotechnology
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company’s commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the... see more

Current News (NDAQ:AXSM)

Axsome Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire November 20, 2025

Pomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Axsome Therapeutics, Inc. Common Stock - AXSM

GlobeNewswire November 10, 2025

Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy

GlobeNewswire November 6, 2025

Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics

GlobeNewswire November 6, 2025

Axsome Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

GlobeNewswire November 3, 2025

Halper Sadeh LLC Encourages Axsome Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Business Wire October 24, 2025

Axsome Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire October 22, 2025

Axsome Therapeutics Recognizes Mental Illness Awareness Week Along with the National Advocacy Community

GlobeNewswire October 9, 2025

Axsome Therapeutics to Report Third Quarter 2025 Financial Results on November 3

GlobeNewswire October 7, 2025
View More News ››

Opinion & Analysis (NDAQ:AXSM)

'Undervalued' Biopharma Gets Breakthrough Status for Alzheimer's Agitation Drug

Streetwise Reports July 2, 2020

Biopharma to Accelerate Alzheimer Trial Completion

Streetwise Reports March 26, 2020

Two Stock-Moving Catalysts Expected in March for Biopharma

Streetwise Reports February 26, 2020

Biopharma's Phase 3 Trial Results in Migraine 'Robust,' 'Impressive'

Streetwise Reports January 6, 2020

Axsome Therapeutics Shares Open 82% Higher on Phase 3 MDD Trial Outcome

Streetwise Reports December 17, 2019

Axsome Therapeutics Investors Awaken to Positive Outcome in Phase 2 Narcolepsy Trial

Streetwise Reports December 4, 2019
View More Opinion ››

Bullboard Posts (NDAQ:AXSM)

5 MOST PROMISING ALZHEIMER’S DISEASE STOCK!

5 MOST PROMISING ALZHEIMER’S DISEASE STOCK! https://www.aviseanalytics.com/5-most-promising-alzheimers-disease-stock/
AviseAnalytics - June 22, 2021

RE:Awesome Run to Over $100 USD

Now 74$. First over 100 soon then?
Marphine - February 12, 2021

Awesome Run to Over $100 USD

We did great buying below $10 We think GNPX will do the same if not better :-) Same pattern https://finance.yahoo.com/quote/GNPX?p=GNPX ...
winemerlotcab67 - February 23, 2020
View more Bullboard ››

Sparta Capital Ltd.

Sparta Capital Ltd.

Sparta Capital Ltd. engages in environment, health, and transportation businesses in Canada. It operates through Electronics ...
View More »